Biotechs soar in premarket; many have strong drug data

NEW YORK (Reuters) – Biotech stocks were among the biggest movers during premarket trading on Thursday, with companies making up more than half of the top 25 most active Nasdaq shares and many reporting massive gains on the back of drug study data.
Go to Source